THE MOSS REPORTS
What is cancer? Is it one disease, or many? It may surprise you
to know that scientists are far from clear on these most fundamental
questions.
Last week I reported on a 2004 experiment at the University of
Massachusetts Medical School (UMSS), showing that some stomach cancers
are caused by microbes and actually originate in bone marrow derived
stem cells (BMDCs). I conclude the article this week.
The model of cancer causation that emerges from this work could
change our understanding of cancer on a fundamental level and has
wide-ranging implications for the future of cancer research as a
whole.
For thirty years I have been monitoring the field of cancer research
and treatment, chronicling the advances and setbacks, the small
triumphs and the many frustrations of the war on cancer.
The fruit of my long involvement in this field is The
Moss Reports, a comprehensive library of more than two hundred
individual reports on specific cancer diagnoses. For cancer patients,
a Moss Report represents an invaluable
guide and handbook for the journey ahead.
If you would like to order a Moss Report
for yourself or someone you love, you can do so from our
website, www.cancerdecisions.com,
or by calling Diane at 1-800-980-1234
(814-238-3367 from outside the US).
We look forward to helping you.
A NEW VIEW OF CANCER'S ORIGINS – PART II
Unitarian Theory?
Conventional thinking states that cancer is a group of 200 or so
different diseases, each of which has its own distinctive features
and causes. In this widely accepted model, lung cancer arises from
normal bodily (or somatic) cells of the lung, those of the liver
from normal liver, and so forth.
In this UMMS experiment, however, Dr. Houghton and her colleagues
clearly demonstrated that the cancer developing in the stomachs
of the experimental animals - despite every appearance to the contrary
- is not really stomach cancer at all. It is caused by the transformation
of bone marrow-derived stem cells, which come rushing to the scene
in order to help, but are then themselves overwhelmed.
Why then do they look so much like malignant stomach cancer cells
that they could fool almost any pathologist who looked at them under
the microscope? Probably because these cells develop within the
distinctive hormonal "microenvironment" of the organ.
To repeat, these "stomach cancer" cells are masquerading,
making themselves appear to be gastric in origin. But their true
nature has now been unmasked: they are in reality stem cells that
have been transformed under the influence of local infection and
inflammation.
It may also turn out that other kinds of carcinoma come about in
the same way. In fact, it is possible that this will develop into
a model for cancer in general, and that in the future we will no
longer be able to talk meaningfully about "stomach," "liver,"
"breast," or other kinds of carcinoma, but all cancers
will be found to have a common origin.
Is cancer then many diseases or one disease with many manifestations?
This is one of the oldest debates in oncology. There have been advocates
of the single origin (or 'unitarian') theory of cancer, even in
conventional medicine. My old boss at Memorial Sloan-Kettering,
Lewis Thomas, MD, believed that cancer would eventually be proven
to be a single disease. But for a long time, it has been the CAM
movement that has provided a refuge for such single-etiology theories.
The classic example of a single, or unitarian, worldview is the
trophoblastic theory of cancer. This was essentially propounded
in 1902 by the Scottish embryologist John Beard, DSc, and then revived
more than half a century ago by Ernst T. Krebs, Jr., and two colleagues.
They proposed that all cancer was identical in nature, and that
its origin was in generally distributed primordial 'diploid totipotent
cells,' which are similar to what are now called stem cells.
Here is what Krebs wrote at mid-century:
"It is veritably impossible to find, among the hundreds of
valid experimental contributions to our knowledge of cancer made
during the past half century, an experimentally established datum
that would controvert the thesis of the basic biological uniformity
characterizing all exhibitions of cancer." (Krebs 1950)
This seemed overblown at the time, but more recent work on stem
cells at the University of Michigan has shown that it is indeed
stem cells, not ordinary somatic cells, that cause breast cancer
in another experimental system. Only a tiny minority of cells in
these human tumors (growing in immune-deficient mice) are capable
of inducing new cancers; the rest are relatively harmless.
"These tumor-inducing cells have many of the properties of
stem cells," said Michael F. Clarke, MD, the Michigan professor
of internal medicine who directed a 2003 study. "They make
copies of themselves - a process called self-renewal – and
produce all the other kinds of cells in the original tumor."
These really malignant cells have a unique configuration of surface
markers: all express a protein marker called CD44, in addition to
having either very low levels, or no levels, of another marker called
CD24.
It will certainly be interesting to see if there is a relationship
between Dr. Houghton's BMDCs and Dr. Clarke's malignant stem cells.
One tell-tale sign would be the presence of these CD44+/CD24- cells.
Another would be the expression of chorionic gonadotropin, the characteristic
hormone of pregnancy.
These are truly exciting times for cancer research. Investigations
of stem cells in many laboratories is homing in on their connection
to the origin of cancer. If such modern discoveries could be combined
with the rich history and practical experience of the CAM movement,
this could lead to a scientifically valid theory of cancer.
Could a cure for cancer be far behind?
--Ralph W. Moss, Ph.D.
References:
Anderson DJ, Gage FH, Weissman IL. Can
stem cells cross lineage boundaries? Nat Med. 2001;7:393-5.
Balkwill F, Mantovani A. Inflammation
and cancer: back to Virchow? Lancet. 2001;357:539-45.
Couzin J. Medicine. Tracing
the steps of metastasis, cancer's menacing ballet. Science.
2003;299:1002-6.
Houghton J, Stoicov C, Nomura S, et al.
Gastric cancer originating from bone marrow-derived cells. Science.
2004;306:1568-71.
Krebs, ET, Jr., Krebs ET, Beard HH.
The unitarian or trophoblastic thesis of cancer. Medical Record
1950;163:149-174.
Normile D. Cell proliferation.
Common control for cancer, stem cells. Science. 2002;298:1869.
UMMS Public Affairs. Bone marrow-derived
stem cells linked to gastric cancers. New thinking on the source
of gastric cancer. Nov, 25, 2004. Accessed Feb. 16, 2005. Available
at:
http://www.umassmed.edu/pap/news/2004/11_25_04.cfm
**NOTE** To view this page
in a more printable format, please CLICK
HERE.
IMPORTANT DISCLAIMER
The news and other items in this newsletter
are intended for informational purposes only. Nothing in this newsletter
is intended to be a substitute for professional medical advice.
 |
|
CancerDecisions®
PO Box 1076, Lemont, PA 16851
Phone Toll Free: 800-980-1234 | Fax: 814-238-5865
Copyright
© 1996-2005 All Rights Reserved |
|
|